Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
98.00    -0.50 (-0.51%)
Bid:
97.60
Ask:
98.10
Spread: 0.50 (0.512%)
Market Cap: £119.07m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Director/PDMR Shareholding

22 Dec 2020 15:39

RNS Number : 5818J
Impax Asset Management Group plc
22 December 2020
 

 

 

 

Impax Asset Management Group plc

 

Director/PDMR Shareholding

Impax Asset Management Group plc (the "Company") announces that it has received notification of the following transactions in ordinary shares in the Company ("Ordinary Shares") by persons discharging managerial responsibilities.

Ian Simm exercised options over 100,000 Ordinary Shares. Charlie Ridge sold 20,000 Ordinary shares at an average price of 636p partly to satisfy tax liabilities arising from the vesting of share awards.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Ian Simm

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Impax Asset Management Group plc

b)

LEI

213800AJDNW4S2B7E680

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of financial instrument

Identification Code

Ordinary Shares of 1p each in Impax Asset Management Group plc

 

IPX

GB0004905260

b)

Nature of the transaction

Ian Simm has exercised options over 100,000 ordinary shares

 

c)

Price(s) and volume(s)

Exercise price(s)

Volume(s)

56.9p per Ordinary Share

100,000

d)

Aggregated information

Aggregated volume

Price

Aggregated volume: 100,000

Aggregated exercise price: 56.9p per Ordinary Share

Total aggregated exercise price: £56,900

 

 

e)

Date of the transaction

21 December 2020

 

f)

Place of the transaction

 

Outside trading venue

 

 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Charlie Ridge

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Impax Asset Management Group plc

b)

LEI

213800AJDNW4S2B7E680

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of financial instrument

Identification Code

Ordinary Shares of 1p each in Impax Asset Management Group plc

 

IPX

GB0004905260

b)

Nature of the transaction

Charlie Ridge has sold 20,000 Ordinary Shares.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

613.87p per Ordinary Share

9,488

656.14p per Ordinary Share

10,512

d)

Aggregated information

Aggregated volume

Price

Aggregated volume: 20,000

Aggregated price: 636.09p

Total aggregated price: £127,217

 

e)

Date of the transaction

21 December 2020

 

f)

Place of the transaction

 

London Stock Exchange

 

LEI number: 213800AJDNW4S2B7E680

-ENDS-

Enquiries:

 

Impax Asset Management Group plc

Ian Simm, Chief Executive

Paul French, Corporate Communications Director

 

 

+44 (0)20 3912 3000

Montfort Communications

Gay Collins

Louis Supple

impax@montfort.london

 

 

+44 (0)77 9862 6282

+44 (0)77 3943 0102

Peel Hunt LLP, Nominated Adviser

James Britton or Rishi Shah

 

+44 (0)20 7418 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVEFTLFFII
Date   Source Headline
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSQ3 AUM update
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20253:43 pmRNSHolding(s) in Company
1st Jul 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20252:16 pmRNS-RInvestor Presentation of Interim Results
22nd May 20257:01 amRNSLaunch of £10m share buyback programme
22nd May 20257:00 amRNSHalf-year Report
14th May 202512:25 pmRNS-RInvestor Presentation of Interim Results
2nd May 20257:00 amRNSNotice of Results
17th Apr 20257:00 amRNSInvestment Advisory Agreement
8th Apr 20257:00 amRNSQ2 AUM update
1st Apr 202512:29 pmRNSAcquisition of fixed income assets
27th Mar 20251:24 pmRNSHolding(s) in Company
13th Mar 20254:28 pmRNSHolding(s) in Company
6th Mar 20253:27 pmRNSHolding(s) in Company
5th Mar 20256:27 pmRNSResult of AGM
5th Mar 20257:00 amRNSAGM Statement
3rd Mar 20256:03 pmRNSHolding(s) in Company
3rd Mar 202510:58 amRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSQ1 AUM update
7th Jan 20259:17 amRNSHolding(s) in Company
17th Dec 20245:44 pmRNSHolding(s) in Company
13th Dec 20244:30 pmRNSNotice of AGM
13th Dec 20247:00 amRNSUpdate on assets under management
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
29th Nov 20245:28 pmRNSForm 8.3 - [Renewi plc]
29th Nov 20244:30 pmRNSPublication of Annual Financial Report
28th Nov 20247:00 amRNSFinal Results
22nd Nov 20242:16 pmRNS-RInvestor Presentation of Full Year Results
20th Nov 20249:30 amRNSNotice of Results
15th Nov 20247:00 amRNSHolding(s) in Company
30th Oct 20243:59 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSQ4 AUM update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.